Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels.
about
Tumor necrosis factor-α inhibitors and chronic hepatitis C: a comprehensive literature reviewHistological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levelsHepatitis C reactivation in patients with chronic infection with genotypes 1b and 2c: a retrospective cohort study of 206 untreated patientsDynamics of Hepatitis C Virus Replication in Human LiverPathological evolution of hepatitis C virus-“Healthy carriers”Diagnosis, management, and treatment of hepatitis C: an updateAn update on the management of hepatitis C: consensus guidelines from the Canadian Association for the Study of the Liver.Non-invasive index of liver fibrosis induced by alcohol, thioacetamide and Schistosomal infection in mice.Histological and clinical characteristics of patients with chronic hepatitis C and persistently normal alanine aminotransferase levelsA comparison of four fibrosis indexes in chronic HCV: development of new fibrosis-cirrhosis index (FCI)Molecular epidemiology of hepatitis C virus infection in an area of hyperendemicity in southern Italy: a population-based study.Roles of the antioxidant properties of icariin and its phosphorylated derivative in the protection against duck virus hepatitis.Identification of a previously undescribed divergent virus from the Flaviviridae family in an outbreak of equine serum hepatitisRelation of insulin resistance and liver fibrosis progression in patients with chronic hepatitis C virus infection.Treatment of patients with hepatitis C and normal serum aminotransferase levels.Rapid normalization of alanine aminotransferase predicts viral response during combined peginterferon and ribavirin treatment in chronic hepatitis C patients.Hepatitis C virus infection: the new global epidemic.Disease progression in chronic hepatitis C patients with normal alanine aminotransferase levels.Should chronic HBV infected patients with normal ALT treated: debate.Pegylated interferon 2a and 2b in combination with ribavirin for the treatment of chronic hepatitis C in HIV infected patients.Should we treat HCV carriers with normal ALT levels? The '5Ws' dilemma.Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment.Diagnosis and Management of Hepatitis C Virus Infection.Infection risk associated with anti-TNF-α agents: a review.Significance of Serum Alpha-Glutathione S-Transferase Assessment in Hepatitis C Patients with Different Alanine Aminotransferase Patterns.Viral persistence, liver disease and host response in Hepatitis C-like virus rat model.Characteristics of hepatitis C virus infection in HIV-infected people.Prognostic factors of hepatic decompensation and hepatocellular carcinoma in patients with transfusion-acquired HCV infection.Lack of clinical and histological progression of chronic hepatitis C in individuals with true persistently normal ALT: the result of a 17-year follow-up.Virological rather than host factors are associated with transaminase levels among HIV/HCV-coinfected patients.Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variation.Patients with chronic hepatitis C and normal transaminases.Rapid virological response as a predictor of sustained response in HCV-infected patients with persistently normal alanine aminotransferase levels: A multicenter study.Increased frequency of IFN-gamma-producing peripheral CD8+ T cells with memory-phenotype in patients with chronic hepatitis C.Efficacy of pegylated interferon plus ribavirin combination therapy for hepatitis C patients with normal ALT levels: a matched case-control study.Healthy range for serum ALT and the clinical significance of "unhealthy" normal ALT levels in the Korean population.Quality of life in HCV-infection: lack of association with ALT levels.Effects of 1-year interferon-alpha 2a treatment in patients with chronic hepatitis C and persistently normal transaminase activity.Hepatitis C virus with normal transaminase levels.Age trend in hepatitis C virus genotype distribution as seen in a Brussels teaching hospital.
P2860
Q26829390-3C414C72-569C-4E58-A999-238F49D90104Q27477959-9F443F0C-680D-40F8-83C2-63F49330B766Q27477975-DD9F722F-0789-4AFB-AE0E-85AE4CBD38AEQ27478394-EB8DFDDF-B97E-4BD5-9D9C-5B5FD591D612Q27489097-402EE6AF-78E6-4C23-863F-1FB73437DBC0Q29619682-DAB4A051-D624-4456-98E7-0CCC05867FEFQ30453975-4D3AA03A-02F9-4EA7-BA40-B78076A0AD66Q33591803-BFE866FC-F3CE-4E68-8047-95247E8727D8Q33660486-81C825AF-24DC-4A62-9DAA-9B681ED168DBQ33877980-186047D8-B3DC-4449-89B7-98C327840FBEQ33961629-8B82CB88-DD95-4233-BF70-94A2CE3FD645Q34256553-006D9E26-61BE-4DC5-9932-0D295E16B5B3Q34627200-02B3122F-CC42-468B-9647-5947CE6076AFQ34747549-BF04F2F7-9023-45BB-829E-9903C7A90704Q34984108-62DF3D39-6F32-4624-957E-6A7664B5005BQ35890604-B666D65B-3C2F-4710-96DE-A401B4B872A3Q36140671-2CEC8016-F57E-42BF-A025-93776B12F5DFQ36770544-019A0220-D02D-451E-A712-06C80596650AQ37278135-E8C9DF57-F4BF-41A0-9A94-F0D64987C85EQ37390380-196272FD-5CF2-499D-A9A3-9208FE534037Q37992183-15AE7F1F-A57A-45D7-A791-D5BD4AE33A6EQ38195262-5EA0DAAC-37C2-455E-92FC-33C7F4484B8FQ38327430-289E8D15-CFDB-4012-94DC-D4115477D249Q38335718-6E00B0F1-B1F1-41E4-925E-D5D09AB890B4Q39106904-9FC0A931-C0FA-4DFA-B5AC-03432069AF20Q40062848-13386A95-7C0F-4596-A373-3D87576FDE07Q40663778-465AEB39-1FA2-4C5F-9D09-A1574899FBCBQ42236954-56645D80-023D-421A-8D94-311A6D84D084Q42271121-301448E0-BA8D-4ACF-B219-695878F419B1Q42994090-89F6D02D-42CF-4515-AE55-C95BE3F778DBQ42994442-821A2FD7-33E4-4118-A889-7E3100084875Q42996773-FDD6E893-16E6-4F36-B6A2-A446E759AE6DQ42997703-3019C9E5-F47C-49FE-B090-56013563E822Q43037757-1DB5BDAD-81A0-42CE-AD60-F6FFA6D654ABQ43039891-15EDD21F-E50D-47DB-9180-2C8FAD356021Q43585965-C67DA469-0D4A-4408-B125-A8110807EB82Q43724091-8574D2DC-7993-4850-AE07-7A41D6F90291Q44006142-567087AC-7D8B-4360-A099-53D3DDAE4736Q45400335-BC54B10C-FC6A-4E1C-A239-978343BF79A3Q45735238-9A525EB4-6B8A-49A5-8A82-4BFFDC3CFC19
P2860
Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Clinical, histological, and vi ...... l alanine transaminase levels.
@en
Clinical, histological, and vi ...... l alanine transaminase levels.
@nl
type
label
Clinical, histological, and vi ...... l alanine transaminase levels.
@en
Clinical, histological, and vi ...... l alanine transaminase levels.
@nl
prefLabel
Clinical, histological, and vi ...... l alanine transaminase levels.
@en
Clinical, histological, and vi ...... l alanine transaminase levels.
@nl
P2093
P356
P1433
P1476
Clinical, histological, and vi ...... l alanine transaminase levels.
@en
P2093
Aldegheri L
Montagnese F
P304
P356
10.1002/HEP.510260603
P407
P577
1997-12-01T00:00:00Z